We are live on
!
Find out more
AAP
Arax Advisory Partners Portfolio holdings
AUM
$3.54B
1-Year Est. Return
19.14%
This Fund
S&P 500
This Quarter
Est. Return
+0.61%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
–
AUM
$1.03B
AUM Growth
+$77.4M
(+8.2%)
Cap. Flow
+$75.9M
Cap. Flow
% of AUM
7.4%
Top 10 Holdings %
Top 10 Hldgs %
30.42%
Holding
2,587
New
1,274
Increased
789
Reduced
244
Closed
48
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares National Muni Bond ETF
MUB
|
+$19M |
| 2 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$3.24M |
| 3 |
Microsoft
MSFT
|
+$2.51M |
| 4 |
NVIDIA
NVDA
|
+$2.31M |
| 5 |
Vanguard Morningstar Small-Cap Value ETF
VBR
|
+$1.86M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Small-Cap Growth ETF
VBK
|
+$1.78M |
| 2 |
iShares Russell Mid-Cap Growth ETF
IWP
|
+$1.69M |
| 3 |
LCG
Sterling Capital Focus Equity ETF
LCG
|
+$953K |
| 4 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$844K |
| 5 |
iShares Russell 2000 Value ETF
IWN
|
+$678K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.63% |
| 2 | Healthcare | 2.97% |
| 3 | Financials | 2.79% |
| 4 | Industrials | 2.3% |
| 5 | Consumer Discretionary | 2.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
BridgeBio Pharma
BBIO
$16.5B
| $1.29K | ﹤0.01% |
+51
| New | +$1.39K |
|
2102
Allient
ALNT
$1.92B
| $1.29K | ﹤0.01% |
+51
| New | +$1.46K |
|
2103
Pioneer Bancorp
PBFS
$434M
| $1.27K | ﹤0.01% |
+127
| New | +$1.21K |
|
2104
Mineralys Therapeutics
MLYS
$2.41B
| $1.26K | ﹤0.01% |
+108
| New | +$1.36K |
|
2105
Alerus Financial
ALRS
$828M
| $1.26K | ﹤0.01% |
+64
| New | +$1.26K |
|
2106
Axogen
AXGN
$2.5B
| $1.25K | ﹤0.01% |
+173
| New | +$1.18K |
|
2107
Myriad Genetics
MYGN
$312M
| $1.25K | ﹤0.01% |
+51
| New | +$1.12K |
|
2108
Bluerock Homes Trust
BHM
$34.9M
| $1.24K | ﹤0.01% |
71
| – | – |
|
|
BASE
2109
DELISTED
Couchbase
BASE
| $1.24K | ﹤0.01% |
+68
| New | +$1.58K |
|
2110
Booz Allen Hamilton
BAH
$9.15B
| $1.23K | ﹤0.01% |
8
+6
| +300% | +$900 |
|
|
IPG
2111
DELISTED
Interpublic Group of Companies
IPG
| $1.22K | ﹤0.01% |
+42
| New | +$1.29K |
|
2112
MYR Group
MYRG
$5.25B
| $1.22K | ﹤0.01% |
+9
| New | +$1.41K |
|
2113
PepGen
PEPG
$197M
| $1.21K | ﹤0.01% |
+76
| New | +$1.09K |
|
2114
Aurora
AUR
$13.8B
| $1.21K | ﹤0.01% |
+436
| New | +$1.21K |
|
2115
Insmed
INSM
$28.6B
| $1.21K | ﹤0.01% |
18
-7
| -28% | -$271 |
|
2116
Nkarta
NKTX
$172M
| $1.21K | ﹤0.01% |
+204
| New | +$1.44K |
|
2117
Revolution Medicines
RVMD
$44B
| $1.2K | ﹤0.01% |
+31
| New | +$1.16K |
|
2118
Pacira BioSciences
PCRX
$997M
| $1.2K | ﹤0.01% |
+42
| New | +$1.2K |
|
2119
Privia Health
PRVA
$2.83B
| $1.2K | ﹤0.01% |
+69
| New | +$1.22K |
|
2120
StepStone Group
STEP
$3.82B
| $1.19K | ﹤0.01% |
+26
| New | +$1.02K |
|
|
AXDX
2121
DELISTED
Accelerate Diagnostics
AXDX
| $1.17K | ﹤0.01% |
1,000
| – | – |
|
2122
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.7B
| $1.17K | ﹤0.01% |
31
| – | – |
|
2123
Kayne Anderson Energy Infrastructure Fund
KYN
$2.4B
| $1.16K | ﹤0.01% |
113
+3
| +3% | +$30 |
|
2124
AGCO
AGCO
$7.2B
| $1.16K | ﹤0.01% |
12
-6
| -33% | -$668 |
|
|
MAGN
2125
Magnera Corp
MAGN
$460M
| $1.16K | ﹤0.01% |
+64
| New | +$1.38K |
|
Similar funds
TYCC
TH
BCP
WWA
VPC
BPS
TCM
DILIC
Arax Advisory Partners's Q2 2024 Portfolio in Review
As of Q2 2024, Arax Advisory Partners held 2,587 positions worth $1.03B, up 8.2% from $948M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Arax Advisory Partners deployed $75.9M of net new capital in Q2 2024, opening 1,274 new positions and adding to 789 existing holdings. Its largest new stake was iShares National Muni Bond ETF: 178,500 shares worth $19M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, up from 4.2% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Vanguard Morningstar Small-Cap Growth ETF, an estimated $1.78M trimmed.
- Arax Advisory Partners's largest Q2 2024 buy was iShares National Muni Bond ETF: 178,500 shares worth $19M.
- Arax Advisory Partners added most to JPMorgan Ultra-Short Income ETF in Q2 2024, an estimated $3.24M increase.
- Arax Advisory Partners's biggest Q2 2024 reduction was Vanguard Morningstar Small-Cap Growth ETF, cutting an estimated $1.78M.
- Arax Advisory Partners fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q2 2024, selling an estimated $166K.
- Arax Advisory Partners's ten largest holdings make up 30% of its $1.03B portfolio in Q2 2024.
- Arax Advisory Partners opened 1,274 new positions and closed 48 in Q2 2024.
- Arax Advisory Partners's portfolio value rose 8.2% quarter-over-quarter to $1.03B.
Based on Arax Advisory Partners's 13F filing for Q2 2024, filed 6 Aug 2024.